Announcement PDF RNS Number : 2869N Pharma C Investments PLC 22 September 2023 22 September 2023 Withdrawal of Requisition for General Meeting Pharma C Investments Plc ("Pharma C" or the "Company") announces that, further to the announcement of 8 September 2023, the requisition calling for a general meeting ("GM") has been withdrawn and therefore at the GM scheduled for 10am on Wed 27 September 2023 at the offices of Hill Dickinson LLP, the resolutions will be withdrawn and not put to members. This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. The Directors of Pharma C accept responsibility for this announcement. END For additional information please contact: Pharma C Investments Gavin Sathianathan, Investment Strategy Director gavin@pharmacinvestments.com Novum Securities (AQSE Corporate Adviser) Tel: +44 207 399 9400 David Coffman This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END NEXVFLFLXKLZBBD